Abstract
Advanced medical technologies are transforming the future of healthcare, in particular, the screening and detection of molecular-genetic changes in patients suspected of having a neoplasm. They are based on the assumption that neoplasms release small amounts of various neoplasm- specific molecules, such as tumor DNA, called circulating DNA (cirDNA), into the extracellular space and subsequently into the blood. The detection of tumor-specific molecules and specific molecular changes in body fluids in a noninvasive or minimally invasive approach is known as “liquid biopsy.” The aim of this review is to summarize the current knowledge of the application of ONT for analyzing circulating DNA in the field of liquid biopsies among cancer patients. Databases were searched using the keywords “nanopore” and “liquid biopsy” and by applying strict inclusion criteria. This technique can be used for the detection of neoplastic disease, including metastases, guiding precision therapy, and monitoring its effects. There are many challenges, however, for the successful implementation of this technology into the clinical practice. The first one is the low amount of tumor-specific molecules in the body fluids. Secondly, a tumor molecular signature should be discriminated from benign conditions like clonal hematopoiesis of unknown significance. Oxford Nanopore Technology (ONT) is a third-generation sequencing technology that seems particularly promising to complete these tasks. It offers rapid sequencing thanks to its ability to detect changes in the density of the electric current passing through nanopores. Even though ONT still needs validation technology, it is a promising approach for early diagnosis, therapy guidance, and monitoring of different neoplasms based on analyzing the cirDNA.
Keywords: Nanopore, cancer, liquid biopsy, sequencing, cfDNA, cirDNA.
[http://dx.doi.org/10.1080/14737159.2022.2065197] [PMID: 35400293]
[http://dx.doi.org/10.1038/s41525-021-00272-y] [PMID: 34887408]
[http://dx.doi.org/10.5005/jp-journals-10024-3240] [PMID: 35748459]
[http://dx.doi.org/10.1016/j.tig.2021.11.003] [PMID: 34906378]
[http://dx.doi.org/10.1016/j.gpb.2016.05.004] [PMID: 27646134]
[PMID: 28637243]
[http://dx.doi.org/10.1021/acs.langmuir.2c00638] [PMID: 35544765]
[http://dx.doi.org/10.1002/asia.202200261] [PMID: 35419929]
[http://dx.doi.org/10.12688/f1000research.12012.2] [PMID: 29375809]
[http://dx.doi.org/10.1093/hmg/ddac112] [PMID: 35567415]
[http://dx.doi.org/10.1007/978-1-0716-2962-8_13]
[http://dx.doi.org/10.1016/j.cgh.2020.02.054] [PMID: 32147593]
[http://dx.doi.org/10.1371/journal.pone.0262468] [PMID: 35025941]
[http://dx.doi.org/10.3389/fimmu.2022.882452] [PMID: 35464472]
[http://dx.doi.org/10.1158/0008-5472.CAN-18-0887] [PMID: 29921699]
[http://dx.doi.org/10.3390/cancers14020310] [PMID: 35053474]
[http://dx.doi.org/10.1007/s00439-020-02227-2] [PMID: 33123832]
[PMID: 18875018]
[PMID: 8118388]
[http://dx.doi.org/10.1038/s41576-018-0071-5] [PMID: 30410101]
[http://dx.doi.org/10.1111/cas.13906] [PMID: 30536551]
[http://dx.doi.org/10.1371/journal.pgen.1006162] [PMID: 27428049]
[PMID: 11245480]
[http://dx.doi.org/10.1186/s12885-023-10681-0] [PMID: 36915069]
[http://dx.doi.org/10.3322/caac.21650] [PMID: 33165928]
[http://dx.doi.org/10.1080/14737159.2020.1724094] [PMID: 32011193]
[http://dx.doi.org/10.1186/s13000-016-0550-y] [PMID: 27724982]
[http://dx.doi.org/10.1186/s12943-021-01327-5] [PMID: 33579306]
[http://dx.doi.org/10.1186/s13059-022-02710-1] [PMID: 35841107]
[http://dx.doi.org/10.1093/clinchem/hvac180] [PMID: 36322427]
[http://dx.doi.org/10.1038/s41431-023-01284-1] [PMID: 36797466]
[http://dx.doi.org/10.1038/s41436-020-0880-8] [PMID: 32624572]
[http://dx.doi.org/10.1158/1078-0432.CCR-20-2066] [PMID: 33087334]
[http://dx.doi.org/10.3389/fonc.2022.958673] [PMID: 36591474]
[http://dx.doi.org/10.1093/nar/gkab812]
[http://dx.doi.org/10.1007/s00401-017-1743-5] [PMID: 28638988]
[http://dx.doi.org/10.7717/peerj.13056] [PMID: 35368340]
[http://dx.doi.org/10.1186/s12864-021-07927-1] [PMID: 34425749]
[http://dx.doi.org/10.4102/ajlm.v9i1.1340] [PMID: 33354530]
[http://dx.doi.org/10.1038/s41587-022-01632-4] [PMID: 36653497]
[http://dx.doi.org/10.1093/bioinformatics/btac359] [PMID: 35639973]
![Wayfinder Image](/images/wayfinder.jpg)